Opus Genetics (IRD) Interest Expenses (2020 - 2026)
Opus Genetics (IRD) reported Interest Expenses of $69000.0 for Q1 2026, up 13.11% on a QoQ basis from $61000.0 in Q4 2025.
Opus Genetics (IRD) has 5 years of Interest Expenses data on file, last reported at $69000.0 in Q1 2026.
- Quarterly Interest Expenses changed N/A year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198000.0 (changed N/A YoY) and the FY2025 annual result came in at $129000.0, changed N/A from the prior year.
- Interest Expenses climbed to $69000.0 in Q1 2026 per IRD's latest filing, from $61000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $69000.0 in Q1 2026 and bottomed at $4000.0 in Q2 2022.
- The 3-year median for Interest Expenses is $61000.0 (2025), against an average of $41400.0.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 5.43 Mn |
| Dec 31, 2020 | 5.43 Mn |
| Sep 30, 2020 | 179,000.00 |
| Sep 30, 2020 | 179,000.00 |
| Jun 30, 2020 | 689,000.00 |
| Jun 30, 2020 | 689,000.00 |
| Mar 31, 2020 | 554,000.00 |
| Mar 31, 2020 | 554,000.00 |